22nd Century Group Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Public

  • Employees
  • 32

Employees

  • Stock Symbol
  • XXII

Stock Symbol

  • Investments
  • 8

  • Share Price
  • $0.76
  • (As of Friday Closing)

22nd Century Group General Information

Description

22nd Century Group Inc is a tobacco products company that enables cigarette smokers to take control of their consumption of nicotine, the addictive drug in cigarettes. The company manufactures and distributes the only combustible tobacco products containing minimally or non-addictive levels of nicotine. The Company has organized its business as a single reportable segment: tobacco, as it operates and derives all revenues from its tobacco operations and products.

Contact Information

Formerly Known As
Touchstone Mining
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 321 Farmington Road
  • Mocksville, NC 27028
  • United States
+1 (336)
Primary Industry
Biotechnology
Stock Exchange
NAS
Corporate Office
  • 321 Farmington Road
  • Mocksville, NC 27028
  • United States
+1 (336)

22nd Century Group Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

22nd Century Group Stock Performance

As of 13-Nov-2026, 22nd Century Group’s stock price is $0.76. Its current market cap is $424K with 551K shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.76 $1.30 $0.72 - $20.3K $424K 551K 745K -$20K

22nd Century Group Financials Summary

As of 30-Jun-2026, 22nd Century Group has a trailing 12-month revenue of $5.17M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV (6,831) 4,945 6,140
Revenue 5,165 7,049 11,878 16,195
EBITDA (11,319) (10,616) (12,185) (40,633)
Net Income (3,926) (5,054) (15,164) (140,775)
Total Assets 26,166 27,023 21,673 27,503
Total Debt 1,749 1,477 8,617 16,378
Public Fundamental Data provided by Morningstar, Inc. disclaimer

22nd Century Group Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore 22nd Century Group‘s full profile, request access.

Request a free trial

22nd Century Group Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
22nd Century Group Inc is a tobacco products company that enables cigarette smokers to take control of their consumption
Biotechnology
Mocksville, NC
32 As of 2025

Ahmedabad, India
 

London, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

22nd Century Group Competitors (8)

One of 22nd Century Group’s 8 competitors is Zydus Lifesciences, a Corporation company based in Ahmedabad, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Zydus Lifesciences Corporation Ahmedabad, India
GSK Corporation London, United Kingdom
Teva Pharmaceutical Industries Corporation Tel Aviv, Israel
Nevian Lifescience Corporate Backed or Acquired Dhaka, Bangladesh
Roche Corporation Basel, Switzerland
You’re viewing 5 of 8 competitors. Get the full list »

22nd Century Group Patents

22nd Century Group Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023034846-A1 Novel molecular markers for sex determination in cannabis Inactive 01-Sep-2021
AU-2021205499-A1 A genetic approach for achieving ultra low nicotine content in tobacco Inactive 08-Jan-2020
CA-3165518-A1 A genetic approach for achieving ultra low nicotine content in tobacco Pending 08-Jan-2020
EP-4087387-A1 A genetic approach for achieving ultra low nicotine content in tobacco Pending 08-Jan-2020
EP-4087387-A4 A genetic approach for achieving ultra low nicotine content in tobacco Pending 08-Jan-2020 A24B13/00
To view 22nd Century Group’s complete patent history, request access »

22nd Century Group Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

22nd Century Group Investments & Acquisitions (8)

22nd Century Group’s most recent deal was a Merger/Acquisition with All About CBD for . The deal was made on 19-Jan-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
All About CBD 19-Jan-2023 Merger/Acquisition Other Pharmaceuticals and Biotechnology
GVB Biopharma 13-May-2022 Merger/Acquisition Pharmaceuticals
Change Agronomy 26-Jan-2022 Corporate Cultivation
Needle Rock Farms 01-Jan-2021 Merger/Acquisition Other Consumer Non-Durables
Panacea Life Sciences 03-Dec-2019 Corporate Other Pharmaceuticals and Biotechnology
You’re viewing 5 of 8 investments and acquisitions. Get the full list »

22nd Century Group ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

45.02 | Severe Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Food Products

Industry

of 508

Rank

Percentile

Tobacco

Subindustry

of 22

Rank

Percentile

To view 22nd Century Group’s complete esg history, request access »

22nd Century Group Exits (4)

22nd Century Group’s most recent exit was on 13-May-2022 from GVB Biopharma. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
GVB Biopharma 13-May-2022 Completed
Needle Rock Farms 01-Jan-2021 Completed
Panacea Life Sciences 03-Dec-2019 Completed
Anandia 18-Sep-2014 Corporate Completed
To view 22nd Century Group’s complete exits history, request access »

22nd Century Group Affiliates

Subsidiaries (4)

Name Industry Location Year Founded
Oregon Custom Supply Grass Valley, OR 2021
Central Oregon Processing Prineville, OR 2019
Ptb Investment Holdings Buffalo, NY 2018
All About CBD Bradford, United Kingdom 2016

22nd Century Group FAQs

  • When was 22nd Century Group founded?

    22nd Century Group was founded in 1998.

  • Where is 22nd Century Group headquartered?

    22nd Century Group is headquartered in Mocksville, NC.

  • What is the size of 22nd Century Group?

    22nd Century Group has 32 total employees.

  • What industry is 22nd Century Group in?

    22nd Century Group’s primary industry is Biotechnology.

  • Is 22nd Century Group a private or public company?

    22nd Century Group is a Public company.

  • What is 22nd Century Group’s stock symbol?

    The ticker symbol for 22nd Century Group is XXII.

  • What is the current stock price of 22nd Century Group?

    As of 13-Nov-2026 the stock price of 22nd Century Group is $0.76.

  • What is the current market cap of 22nd Century Group?

    The current market capitalization of 22nd Century Group is $424K.

  • What is 22nd Century Group’s current revenue?

    The trailing twelve month revenue for 22nd Century Group is $5.17M.

  • Who are 22nd Century Group’s competitors?

    Zydus Lifesciences, GSK, Teva Pharmaceutical Industries, Nevian Lifescience, and Roche are some of the 8 competitors of 22nd Century Group.

  • What is 22nd Century Group’s annual earnings per share (EPS)?

    22nd Century Group’s EPS for 12 months was -$20K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process